PT  - JOURNAL ARTICLE
AU  - Masel, Joanna
AU  - Shilen, Alexandra
AU  - Helming, Bruce
AU  - Rutschman, Jenna
AU  - Windham, Gary
AU  - Judd, Michael
AU  - Pogreba-Brown, Kristen
AU  - Ernst, Kacey
TI  - Quantifying meaningful adoption of a SARS-CoV-2 exposure notification app on the campus of the University of Arizona
AID  - 10.1101/2021.02.02.21251022
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.02.21251022
4099  - http://medrxiv.org/content/early/2021/02/03/2021.02.02.21251022.short
4100  - http://medrxiv.org/content/early/2021/02/03/2021.02.02.21251022.full
AB  - Digital exposure notification requires both the primary and secondary cases to have previously installed a smartphone application, and the primary case to rapidly report their positive diagnosis. These conditions were met for an estimated 12% of transmission pairs during a SARS-CoV-2 outbreak on the campus of the University of Arizona.Competing Interest StatementJM consults for WeHealth PBC (distributors of the Covid Watch Arizona app).Funding StatementFunding was provided by the University of Arizona.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Data were collected under public health surveillance guidelines as part of an evaluation of the system. A request for aggregate data was made by the evaluation team to the Pima County Health Department and University of Arizona privacy officers in consultation with the University of Arizona IRB and was deemed not human subjects research. Data on positive tests were publicly available on the University of Arizona dashboard.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAggregate data is available upon request.